{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:12:41Z","timestamp":1769555561118,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002380","name":"Hanyang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2015R1D1A1A01057243"],"award-info":[{"award-number":["2015R1D1A1A01057243"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2016R1D1A1B03932599"],"award-info":[{"award-number":["2016R1D1A1B03932599"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cancergen.2018.10.005","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T02:46:01Z","timestamp":1541731561000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature"],"prefix":"10.1016","volume":"230","author":[{"given":"Chinmay Satish","family":"Rahane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-6936","authenticated-orcid":false,"given":"Arne","family":"Kutzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0027-6993","authenticated-orcid":false,"given":"Klaus","family":"Heese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cancergen.2018.10.005_bib0001","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.cancergen.2018.10.005_bib0002","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","article-title":"Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?","volume":"30","author":"Kebebew","year":"2006","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.cancergen.2018.10.005_bib0003","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ejca.2013.02.034","article-title":"Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993","volume":"49","author":"Kerkhofs","year":"2013","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.cancergen.2018.10.005_bib0004","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1210\/jc.2017-00174","article-title":"Identification of mutations in cell-free circulating tumor DNA in adrenocortical carcinoma: a case series","volume":"102","author":"Creemers","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.cancergen.2018.10.005_bib0005","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/ERC-17-0440","article-title":"The next step: mechanisms driving adrenocortical carcinoma metastasis","volume":"25","author":"Lalli","year":"2018","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.cancergen.2018.10.005_bib0006","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cancergen.2018.10.005_bib0007","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2013","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.cancergen.2018.10.005_bib0008","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.cancergen.2018.10.005_bib0009","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1530\/EJE-17-0976","article-title":"Mechanisms of endocrinology: cell cycle regulation in adrenocortical carcinoma","volume":"179","author":"Pereira","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.cancergen.2018.10.005_bib0010","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/hmg\/ddq029","article-title":"Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development","volume":"19","author":"Berthon","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.cancergen.2018.10.005_bib0011","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1210\/jc.2011-1982","article-title":"TP53 germline mutations in adult patients with adrenocortical carcinoma","volume":"97","author":"Herrmann","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.cancergen.2018.10.005_bib0012","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2012-2198","article-title":"Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma","volume":"98","author":"Raymond","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.cancergen.2018.10.005_bib0013","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1158\/1078-0432.CCR-10-2006","article-title":"beta-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma","volume":"17","author":"Gaujoux","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"17","key":"10.1016\/j.cancergen.2018.10.005_bib0014","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.cancergen.2018.10.005_bib0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assie","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.cancergen.2018.10.005_bib0016","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"issue":"21","key":"10.1016\/j.cancergen.2018.10.005_bib0017","doi-asserted-by":"crossref","first-page":"8276","DOI":"10.1158\/0008-5472.CAN-10-2014","article-title":"Transcriptome analysis reveals that p53 and \u03b2-catenin alterations occur in a group of aggressive adrenocortical cancers","volume":"70","author":"Ragazzon","year":"2010","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.cancergen.2018.10.005_bib0018","doi-asserted-by":"crossref","first-page":"11421","DOI":"10.18632\/oncotarget.3222","article-title":"Loss of beta-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition","volume":"6","author":"Salomon","year":"2015","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.cancergen.2018.10.005_bib0019","first-page":"6762","article-title":"Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors","volume":"61","author":"Gicquel","year":"2001","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.cancergen.2018.10.005_bib0020","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0653","article-title":"High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors","volume":"95","author":"Sbiera","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.cancergen.2018.10.005_bib0021","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1210\/jc.2004-1075","article-title":"Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy","volume":"90","author":"de Fraipont","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.cancergen.2018.10.005_bib0022","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9440(10)63846-1","article-title":"Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis","volume":"162","author":"Giordano","year":"2003","journal-title":"Am J Pathol"},{"issue":"7484","key":"10.1016\/j.cancergen.2018.10.005_bib0023","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"issue":"6127","key":"10.1016\/j.cancergen.2018.10.005_bib0024","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cancergen.2018.10.005_bib0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"10.1016\/j.cancergen.2018.10.005_bib0026","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"7457","key":"10.1016\/j.cancergen.2018.10.005_bib0027","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"issue":"7132","key":"10.1016\/j.cancergen.2018.10.005_bib0028","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"issue":"13 Supplement","key":"10.1016\/j.cancergen.2018.10.005_bib0029","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1158\/1538-7445.AM2017-2584","article-title":"Abstract 2584: The UCSC Xena system for cancer genomics data visualization and interpretation","volume":"77","author":"Goldman","year":"2017","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.cancergen.2018.10.005_bib0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12031-017-0901-5","article-title":"Cognitive functions: human vs. animal - 4:1 advantage |-FAM72-SRGAP2-|","volume":"61","author":"Ho","year":"2017","journal-title":"J Mol Neurosci"},{"issue":"1","key":"10.1016\/j.cancergen.2018.10.005_bib0031","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/hsz-2017-0190","article-title":"Brain plasticity, cognitive functions and neural stem cells: a pivotal role for the brain-specific neural master gene |-SRGAP2-FAM72-|","volume":"399","author":"Ho","year":"2017","journal-title":"Biol Chem"},{"issue":"5","key":"10.1016\/j.cancergen.2018.10.005_bib0032","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ygeno.2015.07.003","article-title":"All-or-(N)One - an epistemological characterization of the human tumorigenic neuronal paralogous FAM72 gene loci","volume":"106","author":"Kutzner","year":"2015","journal-title":"Genomics"},{"key":"10.1016\/j.cancergen.2018.10.005_bib0033","article-title":"A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature","author":"Rahane","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.cancergen.2018.10.005_bib0034","series-title":"Encyclopedia of clinical neuropsychology","first-page":"2739","article-title":"Z scores","author":"Iverson","year":"2011"},{"issue":"3","key":"10.1016\/j.cancergen.2018.10.005_bib0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cancergen.2018.10.005_bib0036","unstructured":"Team BD. Bokeh: python library for interactive visualization. 2014. Available at: http:\/\/www.bokeh.pydata.org."},{"issue":"7447","key":"10.1016\/j.cancergen.2018.10.005_bib0037","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.328.7447.1073","article-title":"The logrank test","volume":"328","author":"Bland","year":"2004","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.cancergen.2018.10.005_bib0038","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1007\/s13277-013-0999-1","article-title":"The protein p17 signaling pathways in cancer","volume":"34","author":"Heese","year":"2013","journal-title":"Tumour Biol"},{"issue":"2","key":"10.1016\/j.cancergen.2018.10.005_bib0039","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bbrc.2015.06.173","article-title":"LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer","volume":"464","author":"Kou","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"43","key":"10.1016\/j.cancergen.2018.10.005_bib0040","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1038\/onc.2008.185","article-title":"LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII","volume":"27","author":"Stutz","year":"2008","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.cancergen.2018.10.005_bib0041","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1093\/hmg\/9.20.3037","article-title":"Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex","volume":"9","author":"Kirschner","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"7471","key":"10.1016\/j.cancergen.2018.10.005_bib0042","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cancergen.2018.10.005_bib0043","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/sj.onc.1209172","article-title":"CRIPak, a novel endogenous Pak1 inhibitor","volume":"25","author":"Talukder","year":"2006","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.cancergen.2018.10.005_bib0044","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/emboj.2009.336","article-title":"NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development","volume":"29","author":"Miccio","year":"2010","journal-title":"EMBO J"},{"issue":"8","key":"10.1016\/j.cancergen.2018.10.005_bib0045","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nsmb.3250","article-title":"Neddylation requires glycyl-tRNA synthetase to protect activated E2","volume":"23","author":"Mo","year":"2016","journal-title":"Nat Struct Mol Biol"},{"issue":"53","key":"10.1016\/j.cancergen.2018.10.005_bib0046","doi-asserted-by":"crossref","first-page":"90651","DOI":"10.18632\/oncotarget.21544","article-title":"Cancer-mutated ribosome protein L22 (RPL22\/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.cancergen.2018.10.005_bib0047","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bbagen.2009.01.010","article-title":"Mammalian diacylglycerol kinases: molecular interactions and biological functions of selected isoforms","volume":"1790","author":"Topham","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.cancergen.2018.10.005_bib0048","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"10.1016\/j.cancergen.2018.10.005_bib0049","doi-asserted-by":"crossref","first-page":"491","DOI":"10.18632\/oncotarget.271","article-title":"p21-activated kinase 1: PAK'ed with potential","volume":"2","author":"Ong","year":"2011","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cancergen.2018.10.005_bib0050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2006.11.048","article-title":"A Rac-cGMP signaling pathway","volume":"128","author":"Guo","year":"2007","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cancergen.2018.10.005_bib0051","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1892","article-title":"p21-activated kinases in cancer","volume":"6","author":"Kumar","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.cancergen.2018.10.005_bib0052","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BST20160134","article-title":"Targeting PAK1","volume":"45","author":"Semenova","year":"2017","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"10.1016\/j.cancergen.2018.10.005_bib0053","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.cancergen.2018.10.005_bib0054","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1158\/0008-5472.CAN-06-4518","article-title":"Transforming growth factor alpha dependent cancer progression is modulated by Muc1","volume":"67","author":"Pochampalli","year":"2007","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.cancergen.2018.10.005_bib0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12020-016-0941-6","article-title":"Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas","volume":"55","author":"Borsari","year":"2017","journal-title":"Endocrine"},{"issue":"16","key":"10.1016\/j.cancergen.2018.10.005_bib0056","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1038\/sj.emboj.7600342","article-title":"LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation","volume":"23","author":"Gur","year":"2004","journal-title":"EMBO J"},{"issue":"22","key":"10.1016\/j.cancergen.2018.10.005_bib0057","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/onc.2015.345","article-title":"LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells","volume":"35","author":"Yokdang","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cancergen.2018.10.005_bib0058","first-page":"109","article-title":"Harnessing LRIG1-mediated inhibition of receptor tyrosine kinases for cancer therapy","volume":"1868","author":"Neirinckx","year":"2017","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.cancergen.2018.10.005_bib0059","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41389-017-0012-8","article-title":"Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma","volume":"7","author":"Mao","year":"2018","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.cancergen.2018.10.005_bib0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2105-11-150","article-title":"Identifying common prognostic factors in genomic cancer studies: a novel index for censored outcomes","volume":"11","author":"Rouam","year":"2010","journal-title":"BMC Bioinf"},{"issue":"9","key":"10.1016\/j.cancergen.2018.10.005_bib0061","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/neuonc\/not054","article-title":"The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status","volume":"15","author":"Johansson","year":"2013","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.cancergen.2018.10.005_bib0062","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2013.06.116","article-title":"LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR\/topoisomerase-2\/Bcl-2","volume":"437","author":"Qi","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"5\u20136","key":"10.1016\/j.cancergen.2018.10.005_bib0063","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3727\/096504013X13589503482770","article-title":"LRIG1 enhances cisplatin sensitivity of glioma cell lines","volume":"20","author":"Wang","year":"2012","journal-title":"Oncol Res"},{"key":"10.1016\/j.cancergen.2018.10.005_bib0064","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jns.2017.10.025","article-title":"LRIG proteins in glioma: functional roles, molecular mechanisms, and potential clinical implications","volume":"383","author":"Mao","year":"2017","journal-title":"J Neurol Sci"},{"issue":"15","key":"10.1016\/j.cancergen.2018.10.005_bib0065","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/0008-5472.CAN-08-1259","article-title":"Ugene, a newly identified protein that is commonly overexpressed in cancer and binds uracil DNA glycosylase","volume":"68","author":"Guo","year":"2008","journal-title":"Cancer Res"},{"issue":"19","key":"10.1016\/j.cancergen.2018.10.005_bib0066","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/j.febslet.2009.09.018","article-title":"Identification and characterisation of the novel amyloid-beta peptide-induced protein p17","volume":"583","author":"Nehar","year":"2009","journal-title":"FEBS Lett"},{"issue":"12","key":"10.1016\/j.cancergen.2018.10.005_bib0067","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1365-2443.2004.00796.x","article-title":"Differentiation status dependent function of FOG-1","volume":"9","author":"Tanaka","year":"2004","journal-title":"Genes Cells"},{"issue":"4","key":"10.1016\/j.cancergen.2018.10.005_bib0068","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.bbrc.2006.12.155","article-title":"The suppression of zfpm-1 accelerates the erythropoietic differentiation of human CD34+ cells","volume":"353","author":"Yang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"31","key":"10.1016\/j.cancergen.2018.10.005_bib0069","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1200\/JCO.2008.17.5554","article-title":"Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a cancer and leukemia group b study","volume":"26","author":"Marcucci","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.cancergen.2018.10.005_bib0070","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1074\/jbc.M110.195842","article-title":"Insights into association of the NuRD complex with FOG-1 from the crystal structure of an RbAp48.FOG-1 complex","volume":"286","author":"Lejon","year":"2011","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.cancergen.2018.10.005_bib0071","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2013-305715","article-title":"Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4","volume":"64","author":"Li","year":"2015","journal-title":"Gut"},{"issue":"7575","key":"10.1016\/j.cancergen.2018.10.005_bib0072","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nature15510","article-title":"CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase","volume":"526","author":"He","year":"2015","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cancergen.2018.10.005_bib0073","doi-asserted-by":"crossref","first-page":"E640","DOI":"10.1073\/pnas.1200194109","article-title":"Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis","volume":"109","author":"Park","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"708-18","key":"10.1016\/j.cancergen.2018.10.005_bib0074","article-title":"Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping","volume":"11","author":"Kim","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.cancergen.2018.10.005_bib0075","first-page":"68","article-title":"Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study","volume":"9","author":"Wasenius","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"5224","key":"10.1016\/j.cancergen.2018.10.005_bib0076","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.7624798","article-title":"Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27","volume":"269","author":"Pagano","year":"1995","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.cancergen.2018.10.005_bib0077","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1016\/S1569-9056(16)60496-7","article-title":"494 Heat shock protein 90 interactome is highly altered in adrenocortical carcinoma","volume":"15","author":"Prince","year":"2016","journal-title":"European Urology Supplements"},{"issue":"1","key":"10.1016\/j.cancergen.2018.10.005_bib0078","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12929-016-0269-9","article-title":"Zinc finger proteins in cancer progression","volume":"23","author":"Jen","year":"2016","journal-title":"J Biomed Sci"},{"issue":"16","key":"10.1016\/j.cancergen.2018.10.005_bib0079","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1101\/gad.10.16.2067","article-title":"KAP-1, a novel corepressor for the highly conserved KRAB repression domain","volume":"10","author":"Friedman","year":"1996","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.cancergen.2018.10.005_bib0080","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/13892029113149990002","article-title":"KRAB-zinc finger proteins: a repressor family displaying multiple biological functions","volume":"14","author":"Lupo","year":"2013","journal-title":"Curr Genomics"},{"issue":"8","key":"10.1016\/j.cancergen.2018.10.005_bib0081","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1007\/s12035-015-9419-4","article-title":"Loss of diacylglycerol kinase-zeta inhibits cell proliferation and survival in human gliomas","volume":"53","author":"Diao","year":"2016","journal-title":"Mol Neurobiol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218303661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776218303661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:42:15Z","timestamp":1761896535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776218303661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":81,"alternative-id":["S2210776218303661"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.10.005","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}